138 related articles for article (PubMed ID: 21831720)
1. Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms.
Carbone DP; Felip E
Clin Lung Cancer; 2011 Sep; 12(5):261-71. PubMed ID: 21831720
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
Heon S; Johnson BE
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
Reungwetwattana T; Eadens MJ; Molina JR
Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for resected non-small cell lung cancer.
Wakelee H; Chhatwani L
Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
[TBL] [Abstract][Full Text] [Related]
5. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment of early stage non-small-cell lung cancer.
Wada H
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):102-5. PubMed ID: 10442375
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
8. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
Wozniak AJ; Gadgeel SM
Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
[TBL] [Abstract][Full Text] [Related]
10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
11. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
12. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
Wakelee H; Dubey S; Gandara D
Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
[TBL] [Abstract][Full Text] [Related]
13. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
Azzoli CG
Nat Clin Pract Oncol; 2005 Nov; 2(11):552-3. PubMed ID: 16270095
[No Abstract] [Full Text] [Related]
14. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
15. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment of resected nonsmall cell lung cancer: state of the art and new potential developments.
Felip E; Martinez-Marti A; Martinez P; Cedres S; Navarro A
Curr Opin Oncol; 2013 Mar; 25(2):115-20. PubMed ID: 23262832
[TBL] [Abstract][Full Text] [Related]
18. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
Berghmans T
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
[TBL] [Abstract][Full Text] [Related]
19. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
[TBL] [Abstract][Full Text] [Related]
20. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
Socinski MA
Semin Oncol; 1999 Oct; 26(5 Suppl 15):27-33. PubMed ID: 10566608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
